Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Additive Effect of Endonase on the Efficacy of Bismuth-containing Quadruple Therapy as Second-line Treatment for Helicobacter Pylori Infection

NCT01643785 is registered in ClinicalTrials.gov with Chuncheon Sacred Heart Hospital as lead sponsor.

NCT NCT01643785
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01643785 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Additive Effect of Endonase on the Efficacy of Bismuth-containing Quadruple Therapy as Second-line Treatment for Helicobacter Pylori Infection
Lead sponsor
Chuncheon Sacred Heart Hospital
Phase
Not applicable
Overall status
Terminated
Start date
June 30, 2012
Completion date
June 30, 2013
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

helicobacter pylori infection